Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

2.9K
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
2.9K
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.4K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.4K
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

322
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
322
Gene Therapy00:59

Gene Therapy

28.0K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
28.0K
Signs of Puberty01:27

Signs of Puberty

1.9K
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
1.9K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

1.1K
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Italy's Landmark Obesity Law: The Long Road from Science to Policy.

Obesity facts·2026
Same author

Self-Templated Highly Porous Gold Electrodes for Antibiofouling Electrochemical (Bio)Sensors.

Nanomaterials (Basel, Switzerland)·2026
Same author

Capturing metabolic syndrome: new thresholds for insulin resistance and novel body composition indices.

International journal of obesity (2005)·2026
Same author

Author's response to comment re. "Nutri-Score effectiveness at improving consumer nutrition literacy, food choices, health, and healthy eating pattern adherence: A systematic review".

Nutrition (Burbank, Los Angeles County, Calif.)·2025
Same author

Changes of in-vivo markers of platelet activation during the menstrual cycle in healthy pre-menopausal female individuals.

Communications medicine·2025
Same author

Effect of sitagliptin vs. placebo on bone mineralization in women with type 2 diabetes: the SLowDOWN (SitagLiptin in Diabetes for Osteoporosis in WomeN) randomized clinical trial.

BMC medicine·2025
Same journal

Evaluating the Therapeutic Potential of <i>Hyriopsis cumingii</i> Polysaccharide in Osteoarthritis: Insights from a Mouse Model.

Rejuvenation research·2026
Same journal

Baozhu Granule as a Novel Treatment Strategy for Diminished Ovarian Reserve: A Prospective Clinical Trial.

Rejuvenation research·2026
Same journal

Impact of Metformin on Healthspan-Related Outcomes and Incidence of Diseases of Aging in People with Type 2 Diabetes Mellitus: A Systematic Review.

Rejuvenation research·2026
Same journal

Fucoxanthin Promotes Longevity and Neuroprotection in <i>Caenorhabditis elegans</i> via DAF-16 and Autophagy Pathways.

Rejuvenation research·2026
Same journal

Nerolidol Mitigates 3-Nitropropionic Acid-Induced Neurotoxicity: <i>In Silico</i>, <i>In Vitro</i>, and <i>In Vivo</i> Approach.

Rejuvenation research·2026
Same journal

Regular Daily Exercise Improves Sarcopenia in Elderly Patients.

Rejuvenation research·2026
See all related articles

Related Experiment Video

Updated: Mar 22, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

1.7K

Testosterone Replacement Therapy: The Emperor's New Clothes.

Andrea Sansone1, Massimiliano Sansone1, Andrea Lenzi1

  • 1Section of Medical Pathophysiology, Food Science and Endocrinology, Department of Experimental Medicine, Sapienza University of Rome , Rome, Italy .

Rejuvenation Research
|April 29, 2016
PubMed
Summary
This summary is machine-generated.

Global population aging increases healthcare costs. Testosterone replacement therapy (TRT) for late-onset hypogonadism may help symptoms but carries risks, requiring careful patient selection and avoiding anti-aging claims.

Keywords:
agingandropausecardiovascular healthhormonesprostatetestosterone

More Related Videos

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making
11:51

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making

Published on: March 2, 2011

15.8K
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

1.2K

Related Experiment Videos

Last Updated: Mar 22, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

1.7K
Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making
11:51

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making

Published on: March 2, 2011

15.8K
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

1.2K

Area of Science:

  • Gerontology
  • Endocrinology
  • Men's Health

Background:

  • Global population is aging due to increased life expectancy and reduced birth rates.
  • Hormonal changes during aging, like declining testosterone in men, contribute to health issues and reduced well-being.
  • Late-onset hypogonadism is a condition resulting from steadily decreasing testosterone levels in aging males.

Purpose of the Study:

  • To review recent controversies and discoveries concerning testosterone replacement therapy (TRT).
  • To discuss the appropriate use of TRT in aging men and its potential health risks.
  • To provide an overview of current scientific and regulatory perspectives on TRT.

Main Methods:

  • Literature review of recent studies and scientific position statements on TRT.
  • Analysis of Food and Drug Administration (FDA) warnings regarding TRT side effects.
  • Synthesis of information on the benefits, risks, and controversies surrounding TRT.

Main Results:

  • Testosterone levels decline with age in men, potentially leading to late-onset hypogonadism.
  • TRT may alleviate hypogonadism symptoms but is not an anti-aging solution and requires careful patient selection.
  • Conflicting information exists regarding TRT's health risks, with some scientific societies reassuring and the FDA issuing warnings.

Conclusions:

  • TRT should be prescribed judiciously for specific conditions like late-onset hypogonadism, not as a general anti-aging treatment.
  • Ongoing research and discussion are necessary to clarify the long-term safety and efficacy of TRT.
  • Balancing the potential benefits of TRT against its risks is crucial for patient care in aging populations.